Sepehr Abbasi Dezfouli

Dr. Sepehr Abbasi Dezfouli

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 February 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SDSepehr Abbasi Dezfouli
Sepehr Abbasi Dezfouli
UÜUmut Kaan Ünal
Umut Kaan Ünal
OGOmid Ghamarnejad
Omid Ghamarnejad
EKElias Khajeh
Elias Khajeh
SASadeq Ali-Hasan-Al-Saegh
Sadeq Ali-Hasan-Al-Saegh
AMArianeb Mehrabi
Arianeb Mehrabi
Prophylactic drainage after major liver resection remains controversial. This systematic review and meta-analysis evaluate the value of prophylactic drainage after major liver resection. PubMed, Web of Science, and Cochrane Central were searched. Postoperative bile leak, bleeding, interventional drainage, wound infection, total complications, and length of hospital stay were the outcomes of interest. Dichotomous outcomes were presented as odds ratios (OR) and for continuous outcomes, weighted mean differences (MDs) were computed by the inverse variance method. Summary effect measures are presented together with their corresponding 95% confidence intervals (CI). The certainty of evidence was evaluated using the Grades of Research, Assessment, Development and Evaluation (GRADE) approach, which was mostly moderate for evaluated outcomes. Three randomized controlled trials and five non-randomized trials including 5,050 patients were included. Bile leakage rate was higher in the drain group (OR: 2.32; 95% CI 1.18–4.55; p = 0.01) and interventional drains were inserted more frequently in this group (OR: 1.53; 95% CI 1.11–2.10; p = 0.009). Total complications were higher (OR: 1.71; 95% CI 1.45–2.03; p < 0.001) and length of hospital stay was longer (MD: 1.01 days; 95% CI 0.47–1.56 days; p < 0.001) in the drain group. The use of prophylactic drainage showed no beneficial effects after major liver resection; however, the definitions and classifications used to report on postoperative complications and surgical complexity are heterogeneous among the published studies. Further well-designed RCTs with large sample sizes are required to conclusively determine the effects of drainage after major liver resection.

2 May 2017 in Transplant International
Verified
Journal Article
Closed access
PDF file
AMAndré Leopold Mihaljevic
André Leopold Mihaljevic
PHPatrick Heger
Patrick Heger
SDSepehr Abbasi Dezfouli
Sepehr Abbasi Dezfouli
MGMohammad Golriz
Mohammad Golriz
AMArianeb Mehrabi
Arianeb Mehrabi
Lymphocele formation after kidney transplantation is a frequent complication which causes pain, secondary graft loss, rehospitalisations and reoperations. Therefore prophylaxis of lymphocele formation is of utmost importance. To assess the effectiveness of peritoneal fenestration in renal transplantation to prevent lymphocele development A systematic literature search was conducted combined with hand-searches on lymphocele prevention following renal transplantation using peritoneal fenestration. A qualitative and quantitative analysis of included trials was conducted. We identified three trials including 414 patients and 437 transplantations which studied peritoneal fenestration. Only one randomized-controlled trial was identified. Critical appraisal uncovered a number of methodological flaws, predominantly in the non-randomized studies. Most importantly endpoint definitions varied among trials, selection bias was high and interventions and follow-up were not standardized. Meta-analysis of the included trials showed a significant reduction of clinically symptomatic lymphoceles (OR: 0.23, 95%CI: 0.09 to 0.64, p=0.005) and overall postoperative fluid collections (OR: 0.49, 95%CI: 0.28 to 0.88, p=0.02) without a significant increase in other surgical complications. Although peritoneal fenestration is a promising technique to reduce lymphocele formation, only few studies have investigated this technique so fare. Given the low methodological quality of included trials more studies are necessary to evaluate the effectiveness and the risks and benefits of this technique.

31 October 2023 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
SDSepehr Abbasi Dezfouli
Sepehr Abbasi Dezfouli
ARAhmad El Rafidi
Ahmad El Rafidi
EAEhsan Aminizadeh
Ehsan Aminizadeh
ARAli Ramouz
Ali Ramouz
MAMohammed Al-Saeedi
Mohammed Al-Saeedi
AMArianeb Mehrabi
Arianeb Mehrabi
Background: Endocystectomy is a conservative surgical approach to managing cystic echinococcosis. Bile leakage is the main complication of this technique. The aim of this study was to evaluate the factors associated with bile leakage and to assess the outcomes and cost efficiency of strategies used to treat bile leakage. Methodology/Principal findings: Patients who underwent endocystectomy between 2005 and 2020 were included. The preoperative characteristics, intra- and postoperative outcomes, hospital costs, and cost efficiency (the Diagnosis-Related Group reimbursement minus the overall cost) were evaluated prospectively. A total of eighty patients with 142 cysts were included. Postoperative complications occurred in 17 patients (21%), including 11 patients with bile leakage (type A: 1, type B: 6 and type C: 4 patients, total 13%). Bile leakage was more frequent in patients with preoperative MRI signs of cysto-biliary fistulas or intraoperative visible cysto-biliary fistulas (p = 0.03 and p = 0.04, respectively) and in patients with cysts larger than 8 cm (p = 0.03). Patients with bile leakage who underwent reoperation (type C) had significantly shorter hospital stays (9 vs. 16 days, p<0.01) and better cost efficiency than those who received radiologic or endocscopic interventions (€2,072 vs. -€2,097 p = 0.01). No mortality was observed, and recurrence was seen in two patients. Conclusions/Significance: Endocystectomy is a safe and efficient technique. Preoperative and intraoperative cysto-biliary fistulas and a cyst diameter larger than 8 cm are correlated to postoperative bile leakage. Early operative management of bile leakage reduces hospital stay and improves cost efficiency compared with radiologic or endoscopic treatments.

1 October 2019 in Transplantation
Verified
Journal Article
Closed access
ANArash Nickkholgh
Arash Nickkholgh
MNMohammadsadegh Nikdad
Mohammadsadegh Nikdad
SSSaeed Shafie
Saeed Shafie
SDSepehr Abbasi Dezfouli
Sepehr Abbasi Dezfouli
AMArianeb Mehrabi
Arianeb Mehrabi
DMDaniel G. Maluf
Daniel G. Maluf
The disparity between the number of available donor livers and patients awaiting a liver transplant has led transplant centers to accept suboptimal livers. There has been no universally accepted tool to predict the posttransplant function of these organs to safely increase the donor pool, protect these livers against ischemia-reperfusion injury, or improve their quality before implantation. Ex situ liver machine preservation has emerged as a promising novel graft protective strategy in the field of liver transplantation, with remarkable ongoing research and evolving clinical trials within Europe and the United States. This technology has been shown to be safe and feasible in the clinical liver transplantation field, has shown to reduce liver ischemia-reperfusion injury, and has shown to decrease the graft discard rate compared with conventional static cold storage. This review focuses on the current status of ex situ machine preservation in clinical liver transplantation, describing the most important technical aspects with the emphasis on the findings of the most recent clinical studies.

21 January 2022 in BMC Cancer
Verified
Journal Article
Open access
PDF file
EKElias Khajeh
Elias Khajeh
AMArash Dooghaie Moghadam
Arash Dooghaie Moghadam
PEPegah Eslami
Pegah Eslami
SASadeq Ali-Hasan-Al-Saegh
Sadeq Ali-Hasan-Al-Saegh
ARAli Ramouz
Ali Ramouz
AMArianeb Mehrabi
Arianeb Mehrabi
Background: Hepatocellular carcinoma (HCC) is the sixth most common form of cancer worldwide. Although surgical treatments have an acceptable cure rate, tumor recurrence is still a challenging issue. In this meta-analysis, we investigated whether statins prevent HCC recurrence following liver surgery. Methods: PubMed, Web of Science, EMBASE and Cochrane Central were searched. The Outcome of interest was the HCC recurrence after hepatic surgery. Pooled estimates were represented as hazard ratios (HRs) and odds ratios (ORs) using a random-effects model. Summary effect measures are presented together with their corresponding 95% confidence intervals (CI). The certainty of evidence was evaluated using the Grades of Research, Assessment, Development and Evaluation (GRADE) approach. Results: The literature search retrieved 1362 studies excluding duplicates. Nine retrospective studies including 44,219 patients (2243 in the statin group and 41,976 in the non-statin group) were included in the qualitative analysis. Patients who received statins had a lower rate of recurrence after liver surgery (HR: 0.53; 95% CI: 0.44–0.63; p < 0.001). Moreover, Statins decreased the recurrence 1 year after surgery (OR: 0.27; 95% CI: 0.16–0.47; P < 0.001), 3 years after surgery (OR: 0.22; 95% CI: 0.15–0.33; P < 0.001), and 5 years after surgery (OR: 0.28; 95% CI: 0.19–0.42; P < 0.001). The certainty of evidence for the outcomes was moderate. Conclusion: Statins increase the disease-free survival of patients with HCC after liver surgery. These drugs seem to have chemoprevention effects that decrease the probability of HCC recurrence after liver transplantation or liver resection.

10 March 2022 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
ARAli Ramouz
Ali Ramouz
MHMohammadreza Hafezi
Mohammadreza Hafezi
SASadeq Ali-Hasan-Al-Saegh
Sadeq Ali-Hasan-Al-Saegh
SSSaeed Shafiei
Saeed Shafiei
SDSepehr Abbasi Dezfouli
Sepehr Abbasi Dezfouli
AMArianeb Mehrabi
Arianeb Mehrabi